$9.82
-0.13-1.31%
Last update: Aug 26, 4:12 PM
ImmuCell Corp
ICCCNASDAQ
ImmuCell Earnings & Forecasts
ImmuCell (ICCC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
ImmuCell Guidance
ImmuCell (ICCC) last issued guidance on July 9, 2026 for Q2 2026. The company guided revenue in the range of $7.2M - $7.2M for the period.
Compared to prior guidance, ImmuCell lowered its revenue forecast from a prior range of $10.4M - $10.4M.
ImmuCell has issued 21 guidance updates between October 5, 2022 and July 9, 2026. During this period, the company raised its outlook 8 times and lowered it 12 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $0.20 | $0.21 | $-0.31 | $-0.02 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $7.2M | $10.4M | $7.6M | $5.5M |
| Surprise | — | — | — | — |
